Alliance Pharma gains Nizoral in Asia-Pacific

19 June 2018 - Deborah Wilkes

Archived

Alliance Pharma is acquiring the marketing rights to Johnson & Johnson's Nizoral anti-dandruff shampoo in the Asia-Pacific region for GBP60.0 million (USD79.2 million).

Click tags below for more information on topics:

Alliance Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: